Results 201 to 210 of about 55,383 (212)

Progress in the development of human parainfluenza virus vaccines

Expert Review of Respiratory Medicine, 2011
Anne Schaap-Nutt, Emmalene J Bartlett, Ruth A Karron   +2 more
exaly  

Syntheses of 2-deoxy-2,3-didehydro-N-acetylneuraminic acid analogues modified by N-sulfonylamidino groups at the C-4 position and biological evaluation as inhibitors of human parainfluenza virus type 1

Bioorganic and Medicinal Chemistry, 2011
Tadanobu Takahashi
exaly  

Safety and immunogenicity of intranasal murine parainfluenza virus type 1 (Sendai virus) in healthy human adults

Vaccine, 2004
Karen S Slobod, Jerry L Shenep, Jorge Luján-Zilbermann   +2 more
exaly  

The conserved carboxyl terminus of human parainfluenza virus type 2 V protein plays an important role in virus growth

Virology, 2007
Machiko Nishio, Masato Tsurudome, Hisamitsu Ishihara   +2 more
exaly  

Interaction of human parainfluenza virus type 3 with the host cell surface

The Pediatric Infectious Disease Journal, 1997
openaire   +2 more sources

Human parainfluenza virus types 1–4 in hospitalized children with acute lower respiratory infections in China

Journal of Medical Virology, 2016
Ni-Guang Xiao, Zhao-Jun Duan, Zhi-Ping Xie   +2 more
exaly  

A Point Mutation in the RNA-Binding Domain of Human Parainfluenza Virus Type 2 Nucleoprotein Elicits Abnormally Enhanced Polymerase Activity

Journal of Virology, 2017
Yusuke Matsumoto, Keisuke Ohta, Machiko Nishio   +2 more
exaly  

Clinical characteristics of the lower respiratory tract infection caused by a single infection or coinfection of the human parainfluenza virus in children

Journal of Medical Virology, 2019
Peipei Zhong, Hailin Zhang
exaly  

Evaluation of xTAG Respiratory Viral Panel FAST and xTAG Human Parainfluenza Virus Analyte-Specific Reagents for detection of human parainfluenza viruses in respiratory specimens

Diagnostic Microbiology and Infectious Disease, 2012
Rangaraj Selvarangan
exaly  

Human parainfluenza virus type I (HPIV1) vaccine candidates designed by reverse genetics are attenuated and efficacious in African green monkeys

Vaccine, 2005
Emmalene J Bartlett, Emerito Amaro-Carambot, Sonja R Surman   +2 more
exaly